Figure 1.  ESMO Asia Congress 2017

The European Society for Medical Oncology (ESMO) opened once again its 3rd ESMO Asia Congress on November 17th 2017 in Suntec Convention and Exhibiton, Singapore. The event was attracting close to 3000 regional and international cancer doctors with leading researchers and experts who promoted advances technology in science, diagnosis, treatment, and best practices for cancer patients in Asia. The inaugural ESMO Asia Congress was held in 2015 in Singapore where medical professionals, representing various oncology disciplines from 75 countries, came together to discuss and share key research and developments in oncology. This year, the Congress is supported by 21 oncology associations in the region, including the Singapore Society of Oncology and oncology societies from Australia, Bangladesh, China, Hong Kong, India, Indonesia, Iran, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, South Korea, Taiwan, Thailand, and Uzbekistan.

The ESMO asia invited the worlwide experts to share about many topics, including Central Nervous System (CNS) tumor, Breast Cancer, Colorectal Cancer, Head and Neck Cancer, Immune based cancer treatment, drug development, and other treatment practice guidelines to treat cancer patients. Immunotherapy was still the hot topic among oncology enthusiast because of its promising potential to cure cancer in the future. Specialized colloquia also discussed about harnessing the artificial intellegence (AI) advancement to solve cancer problems.

Stem Cell and Cancer Institute (SCI) Jakarta, as one of the leader in oncology research fields in Indonesia, sent its delegates to present the research data as well as represented the SCI in international community. This year, SCI sent 3 research posters, presented by Ahmad R. Utomo (Principal Investigator) and Gintang Prayogi (Research Assistant), and a delegate for oral presentation session, presented by dr. Patricia Diana (Consultant Patholog). The posters and oral presentation represented the SCI research activites on the Central Nervous System (CNS) Cancer, Breast Cancer, and Colorectal Cancer fields.

Figure 2.  SCI Delegates, from left to right, Ahmad R. Utomo (green batik),
Gintang Prayogi (grey shirt), Patricia Diana (brown batik)

In summary, participation in international event is necessary for SCI to improve the knowledge and insight about cancer issue in additon to strenghten SCI existence in international scientific community. Active discussion with other scientist in the region is helpful to benchmarking the research quality and to build up the network as well. Exposure from the expertise, including the critics and comments, is important to enhance our research in return to ascertain the ultimate research benefit for indonesian cancer patient.

Post Rating


There are currently no comments, be the first to post one.

Post Comment

Only registered users may post comments.

News & Events



SCI - Events

Stem Cell News

Cell Therapy News

Cancer News

Internship Program